Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. All content is Derek’s own, and he does not in any way speak for his employer.

By Derek Lowe

Posts tagged with "Biological News"

• Analytical Chemistry

  The Good Stuff Goes One Way. . .

  6 February, 2019

  I’ve always like the idea of aptamers – as generally used, that word refers to oligonucleotides that are selected for binding to something else (a protein target, for example). You get to use all the tools of molecular biology, which means that you can start out from insanely huge numbers of possible binders and select… Read More

• Biological News

  Precision Medicine Real Soon Now

  31 January, 2019

  Here’s a strongly opinionated look at where the “precision medicine” field is these days, and I think that this is just the sort of article that the field (and the journalists covering it) need to see, whether you agree with it or not: In 1999 Francis Collins published a foundational document of precision medicine entitled… Read More

• Biological News

  Exercise And Its Signaling

  24 January, 2019

  It’s a truism among metabolic researchers that if you could find a drug that simulates the effects of exercise you would be very happy with the market for it. But what causes the effects of exercise? That’s one of those simple questions that members of the general public might think that they know the answer… Read More

• Biological News

  Quinine’s Target

  22 January, 2019

  Every “history of pharmaceuticals” article ever written probably mentions quinine, and well they should. (I certainly reserved an entry for it while writing my own chemical history book). It’s a classic example of a natural product drug, one that was not known to the classical Mediterranean world but was only appreciated by Europe… Read More

• Biological News

  Bacteria and Depression: Something to Test

  17 January, 2019

  Microbiome, microbiome – you haven’t been able to turn around in this business the last few years without hitting some sort of story about the microbiome. It’s easy to roll your eyes and decide that it’s all hype, but that’s the thing: it really is important. It can’t be dismissed just because we don’t unde… Read More

• Biological News

  Room For Improvement

  8 January, 2019

  How much can we improve on Nature? Fixing defective proteins and pathways is one thing, but in those cases we’re trying to get back to what the function should be (and what it is in healthy organisms). But what about “better than healthy”? That’s a tricky area to enter, because (for one thing) billions of… Read More

• Biological News

  We Have Given People Amyloid Disease

  17 December, 2018

  Unfortunately, it’s time to talk transmissible protein pathology again. That’s the unnerving idea that misfolded proteins can, under some conditions, act as infectious agents (prions are the most famous examples and the most widely-used name for these). I wrote in 2015 about a particularly alarming possibility. It’s known that up… Read More

• Biological News

  Right Side, Left Side

  13 December, 2018

  I wrote here about chirality, on several levels, finishing up with some speculations on how we know our left hands from our right and why. As mentioned in that post, that’s one of those questions that can sound stupid and/or trivial until you start to think about it, and as the comments section proved, things… Read More

• Biological News

  Tumor-Specific Antigens From Way Out There

  11 December, 2018

  The pileup in immuno-oncology is already the stuff of legend: it’s difficult to even count the number of therapies, combinations, and clinical trials that are underway or in development. And that’s for good reason, of course – the promise here is huge, the field is wide open, and there are vast tracts of things that… Read More

• Alzheimer's Disease

  The Genomics of Neurons. And Alzheimer’s. And Everything Else.

  29 November, 2018

  The brain is a complicated organ. Let’s start there. It’s complicated at every level that you care to examine, and if you get down to the genomic sequences of individual neurons, it’s worse than ever. The sheer variety of neurons and other cell types is quite extreme, and a lot of work over the years… Read More